Market Place
Sourcing Support
All News #Library
Biotech
Affimed Files for Insolvency Proceedings
13 May 2025 //
GLOBENEWSWIRE
Affimed Reports Update on AFM24/Atezolizumab Combo for NSCLC
17 Dec 2024 //
GLOBENEWSWIRE
Affimed Hosts Investor Call on AFM24 & Atezolizumab in NSCLC
09 Dec 2024 //
GLOBENEWSWIRE
Affimed: Acimtamig and AlloNK® Positive in Relapsed Hodgkin Lymphoma
08 Dec 2024 //
GLOBENEWSWIRE
Affimed`s Acimtamig & AlloNK® Granted RMAT Designation by FDA
05 Dec 2024 //
GLOBENEWSWIRE
Affimed`s AFM24 Combo Shows Durable Responses In Pretreated NSCLC
01 Jun 2024 //
GLOBENEWSWIRE
Affimed Gets Fast Track For AFM24-Atezolizumab In NSCLC
29 May 2024 //
GLOBENEWSWIRE
Affimed Early Efficacy Results: Afm24-102 Egfrwt Nsclc At Asco 2024
23 May 2024 //
GLOBENEWSWIRE
Affimed`s AFM24 Abstract at ASCO 2024
24 Apr 2024 //
GLOBENEWSWIRE
Affimed Reports 2023 Financial Results and Operational Progress
28 Mar 2024 //
GLOBENEWSWIRE
Affimed Announces Phase 1/2 Data from Acimtamig with Allogeneic NK in Lymphoma
11 Dec 2023 //
GLOBENEWSWIRE
Affimed Announces Positive Data for AFM24 in Combination with Atezolizumab
11 Dec 2023 //
GLOBENEWSWIRE
AbCheck Announces Collaboration to Apply Microfluidics Technology to Antibodies
21 Feb 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.